Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,1.23 [1.1-1.37],0.000269824366502539,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,1.51 [1.2-1.91],0.00050354225599314,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.11 [1.03-1.19],0.00448246254935276,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.04 [1.01-1.08],0.0123954065479303,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.07 [1.01-1.12],0.0124066844662998,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.13 [1.02-1.26],0.0196362565118104,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.03 [1-1.05],0.0200781387909232,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.15 [1.02-1.29],0.0236901673329786,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1.04 [1-1.08],0.0256224549181564,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.04 [1-1.08],0.0347788536100543,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,CD2_NONFOLLICULAR_LYMPHOMA_EXALLC,Inverse variance weighted,2,0.94 [0.88-1],0.0353119958425846,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.03 [1-1.07],0.0498833407174557,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.04 [1-1.09],0.0675745844258405,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.77 [0.58-1.03],0.0822155470801808,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,1.04 [0.99-1.1],0.104797003578792,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,7,1.18 [0.96-1.45],0.124845552671005,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1.02 [0.99-1.05],0.127894020688984,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,12,0.96 [0.91-1.02],0.169596789974251,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1.01 [0.99-1.03],0.178126136840756,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,1.07 [0.96-1.19],0.210241252163943,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,1.17 [0.91-1.51],0.211339393623249,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.12 [0.94-1.33],0.212258807087002,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,52,1.02 [0.99-1.06],0.223425423743335,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.28 [0.84-1.96],0.249118967569536,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,8,1.01 [0.99-1.03],0.26639404268547,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,1.03 [0.98-1.08],0.270661963628745,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.12 [0.91-1.36],0.276569801676167,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,0.8 [0.54-1.2],0.280584986085315,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,5,1.04 [0.97-1.11],0.281210020052572,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1.02 [0.98-1.06],0.296231674702,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.01 [0.99-1.04],0.303746252664438,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,1.01 [0.99-1.04],0.316464190321061,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.89 [0.72-1.12],0.322778674799925,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.07 [0.93-1.23],0.342672943457732,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,1.06 [0.93-1.21],0.353827182302303,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,0.99 [0.96-1.02],0.380409983986113,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.01 [0.99-1.02],0.380622111981375,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.06 [0.92-1.23],0.403213397102093,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.05 [0.94-1.17],0.404580576020273,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,15,1 [0.99-1],0.418112767103141,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.12 [0.85-1.46],0.420854424607963,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.89 [0.66-1.2],0.444792326493481,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,0.98 [0.92-1.04],0.464820450763732,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.05 [0.92-1.19],0.470490293408651,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.93 [0.76-1.14],0.481083296298611,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.08 [0.87-1.33],0.504080626713327,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,0.95 [0.83-1.1],0.50520297111988,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,1.09 [0.83-1.43],0.530738357914089,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,0.98 [0.91-1.05],0.53122911887409,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1.11 [0.79-1.56],0.561793172013152,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,1.02 [0.95-1.11],0.565602036204827,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,1.35 [0.44-4.12],0.59926346268037,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,1.03 [0.92-1.16],0.618638651554563,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.93 [0.68-1.27],0.650361673211198,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1.02 [0.93-1.13],0.652158347564474,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.99 [0.93-1.05],0.703338841409635,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,4,1.01 [0.95-1.08],0.716251188965536,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.96 [0.76-1.21],0.718371163752824,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.02 [0.91-1.13],0.756049266183114,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.04 [0.82-1.32],0.769161654720837,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,0.98 [0.8-1.2],0.840588737444933,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,1 [0.97-1.04],0.84416966535836,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Wald ratio,1,0.99 [0.95-1.05],0.845118418787975,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.99 [0.93-1.07],0.858475914485106,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,1 [0.97-1.02],0.876926584766184,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,1 [0.95-1.06],0.893284680192734,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1 [0.92-1.08],0.919924702959659,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,122,1 [0.97-1.03],0.922874681173445,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,1 [0.94-1.07],0.923979644223215,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1 [0.95-1.05],0.962166004575311,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.99 [0.73-1.35],0.969613355553834,trans
